Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases
Benjamin Frey, Michael Rückert, Lisa Deloch, et al.
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 231-248
Closed Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Targeting TGF-β signal transduction for fibrosis and cancer therapy
Dandan Peng, Minyang Fu, Manni Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 571
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 421
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
Yu Kato, Kimiyo Tabata, Takayuki Kimura, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0212513-e0212513
Open Access | Times Cited: 370
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
Yifan Wang, Weiye Deng, Nan Li, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 334
Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells
Abraham Lin, Yury Gorbanev, Joey De Backer, et al.
Advanced Science (2019) Vol. 6, Iss. 6
Open Access | Times Cited: 213
Radiation-induced skin reactions: mechanism and treatment
Jinlong Wei, Lingbin Meng, Xue Hou, et al.
Cancer Management and Research (2018) Vol. Volume 11, pp. 167-177
Open Access | Times Cited: 178
Low dose ionizing radiation effects on the immune system
Katalin Lumniczky, Nathalie Impens, Gemma Armengol, et al.
Environment International (2020) Vol. 149, pp. 106212-106212
Open Access | Times Cited: 169
Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts
D. Averbeck, Claire Rodriguez‐Lafrasse
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11047-11047
Open Access | Times Cited: 138
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Radiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms
Jinlong Wei, Bin Wang, Huanhuan Wang, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 145
Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics
Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, et al.
Clinical & Translational Oncology (2018) Vol. 20, Iss. 8, pp. 975-988
Open Access | Times Cited: 131
Radiotherapy–immunotherapy combinations – perspectives and challenges
Michele Mondini, Antonin Lévy, Lydia Meziani, et al.
Molecular Oncology (2020) Vol. 14, Iss. 7, pp. 1529-1537
Open Access | Times Cited: 130
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
Florian Wirsdörfer, Simone de Leve, Verena Jendrossek
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 24-24
Open Access | Times Cited: 126
SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges
Yu Chen, Min Gao, Zhaoqin Huang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 125
CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance
Michele Mondini, Pierre-Louis Loyher, Pauline Hamon, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 3, pp. 376-387
Open Access | Times Cited: 108
NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
Keywan Mortezaee, Masoud Najafi, Bagher Farhood, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 10, pp. 17187-17204
Closed Access | Times Cited: 107
Comparison of DNA repair and radiosensitivity of different blood cell populations
Daniel Heylmann, Viviane Ponath, Thomas Kindler, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 101
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Michael Rückert, Lisa Deloch, Rainer Fietkau, et al.
Strahlentherapie und Onkologie (2018) Vol. 194, Iss. 6, pp. 509-519
Closed Access | Times Cited: 100
Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Marka R. Crittenden, Lauren Zebertavage, Gwen Kramer, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 98
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
Shweta Joshi, Donald L. Durden
Journal of Oncology (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 98
Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine
Sara S. Bashraheel, Alexander Dömlingꝉ, Sayed K. Goda
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 110009-110009
Open Access | Times Cited: 97
Radioimmunotherapy for the treatment of head and neck cancer
Sana D. Karam, David Raben
The Lancet Oncology (2019) Vol. 20, Iss. 8, pp. e404-e416
Closed Access | Times Cited: 93
Radiotherapy and the immune system: More than just immune suppression
Michael Rückert, Ann-Sophie Flohr, Markus Hecht, et al.
Stem Cells (2021) Vol. 39, Iss. 9, pp. 1155-1165
Open Access | Times Cited: 87
Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System
Sylvia E. Falcke, Paul F. Rühle, Lisa Deloch, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3574-3574
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top